Urgency Urinary Incontinence Clinical Trial
Official title:
Investigation of Brain Mechanisms Involved in the Urinary Continence Mechanism Associated With Aging
Urge urinary incontinence (UUI) is a common problem in older people which vastly reduces quality of life, yet the cause and mechanism of disease are not well understood. This study will characterize brain control of the bladder in young and old continent individuals and age-matched incontinent counterparts. This will expand the investigators current knowledge of how the brain controls the bladder, how that control changes with age and disease, and suggest new targets to guide development of better treatment.
Status | Recruiting |
Enrollment | 190 |
Est. completion date | November 30, 2025 |
Est. primary completion date | May 31, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - 'Old' (community-dwelling, mentally and functionally intact ambulatory women aged 65+ years) or 'Young' (equivalent women aged 18-45) - 'Wet' (those who meet the International Continence Society definition of urgency urinary incontinence (urinary leakage accompanied by a sudden, strong urge to void which is difficult to defer) >5 times per week, for 3 months despite treatment for reversible causes (e.g., Urinary tract infection) and confirmed by a mean of one episode per day of UUI on 3-day bladder diary) or 'Dry' (women without current or past UUI or other lower urinary tract symptoms.) Infrequent stress incontinence of a small amount is acceptable. - Urge-predominant mixed incontinence is acceptable provided the subject is able to differentiate between stress incontinence (SUI - leakage that coincides instantaneously with cough, laugh, exercise) and urgency incontinence, i.e., leakage accompanied by a sudden strong urge to void that is difficult to defer. - Those with current or previous use of anticholinergic/beta-3 agonist medications will be considered for the study if they are willing to go through a washout period of at least 4 weeks of duration. Exclusion Criteria: Dry Groups - Current or prior treatment for UUI - Leakage on bladder diary not ascribed to minimal SUI (see bullet above) All Groups: 'Wet' or 'Dry'; 'Young' or 'Old' - Cognitive impairment: - MoCA<26 - inability to perform a voiding diary/pad test - inability to reliably take daily medication - inability to comply with fMRI testing - Impaired mobility o Timed up and go test = 12 secs - Medical instability: - severe uncontrolled hypertension >180mmHg systolic or >100mmHg diastolic - potential major changes in medical management over the course of the study period (i.e. upcoming surgery/treatment) - frailty according to the Fried criteria - MRI incompatibility: - contraindicated metal implants - claustrophobia - unidentified/untested compatibility of metal implants - Medication incompatibility: - allergy to study medication (all prophylactic antibiotic choices) - interaction of prophylactic antibiotic choices with current medications - expected change in medication during the study - Neurological conditions: - spinal cord injury; - multiple sclerosis - clinically apparent lesions (e.g. lacunae associated with stroke) - prior stroke - Parkinson's Disease/ALS/MSA - any clinically apparent neurological condition - Lower urinary tract comorbidities/treatment: - history of pelvic irradiation - bladder or advanced uterine cancer - possible urethral obstruction (advanced prolapse [POP-Q>II] or Qmax<12 ml/s on free flow) - urinary retention (PVR >200 ml) - Interstitial Cystitis/Bladder Pain Syndrome - artificial sphincter implant - Botox treatment for UUI within 1 year - Neuromodulation treatment for UUI - Other comorbidities: - uncontrolled depression (PHQ-9 =10) |
Country | Name | City | State |
---|---|---|---|
United States | University of Pittsburgh | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh | National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | BOLD (Blood oxygen level dependent) fMRI signal contrast | BOLD signal contrast - voxel-wise subtraction of normalized brain activity signal measure (BOLD response) during bladder fluid withdrawal from that during bladder infusion. Magnitude of BOLD contrast is then compared using ANOVA to compare the four groups (old dry/old wet/young dry/young wet). Differences are displayed as a map of t-values for each voxel of the brain, showing likelihood of statistical significance of differences. A priori regions of interest i.e. the bed nucleus of the stria terminalis (BST), pontine micturition center (PMC), periaqueductal grey (PAG), insula, medial prefrontal cortex (mPFC), dorsal anterior cingulate cortex/supplementary motor area (dACC/SMA) will be specified. Since BOLD signal represents the normalized contrast in fMRI signal between two states as a proxy for cerebral blood flow, it does not have a unit. | 20 minutes of a 1 hour MRI scan | |
Secondary | Changes in brain structural integrity | Difference in structural integrity of connective tracts will be compared using ANOVA to compare the four groups (old dry/old wet/young dry/young wet). Measure of structural integrity (normalized quantitative anisotropy, NQA), which describes the diffusion of water molecules around neuronal compartments (e.g., myelin, neurofilaments and microtubules) will be extracted from each individual and compared across groups. | 15 minutes of 1 hour MRI scan | |
Secondary | Changes in brain structural integrity | Difference in structural integrity of connective tracts will be compared using ANOVA to compare the four groups (old dry/old wet/young dry/young wet). Measure of structural integrity (generalized fractional anisotropy, GFA), which describes the diffusion of water molecules around neuronal compartments (e.g., myelin, neurofilaments and microtubules) will be extracted from each individual and compared across groups. | 15 minutes of 1 hour MRI scan | |
Secondary | Functional connectivity during infusion/withdrawal task | Functional connectivity calculated using generalized psychophysiological interaction (gPPI) analysis for each ROI (Eigenvariate time series; no units) will be extracted from the BOLD signal and a regression analysis performed, modeling the infusion/withdrawal blocks and the a priori ROI time series (mPFC, dACC/SMA, Insula) and its interactions with 'infuse' and 'withdraw' blocks. | 20 minutes of 1 hour MRI scan | |
Secondary | Resting state analysis | Resting state connectivity will be calculated by extracting the eigenvariate (no units) of three a priori selected ROIs (mPFC, dACC/SMA, Insula) and calculate voxel-wise connectivity maps for each region. Regional homogeneity evaluates regional changes in connectedness corresponding to local activation (temporal and spatial) between groups. | 10 minutes of 1 hour MRI scan | |
Secondary | Differences in volume of brain structures | Difference in grey matter volume (mm^3) on MRI as calculated by voxel based morphometry using ANOVA to compare the four groups (old dry/old wet/young dry/young wet). Grey matter volume of important brain structures will be compared. | 10 minutes of 1 hour MRI scan | |
Secondary | Differences in white matter damage of brain structures | Difference in volume of white matter damage (mm^3) on MRI using ANOVA to compare the four groups (old dry/old wet/young dry/young wet). Global volume of white matter damage will be compared. along with damage location. | 10 minutes of 1 hour MRI scan |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05557175 -
Repetitive Transcranial Magnetic Stimulation (rTMS) on Neurogenic Overactive Bladder in Stroke
|
N/A | |
Recruiting |
NCT05512039 -
Reduced-dose Botox for Urgency Incontinence Among Elder Females
|
Phase 1/Phase 2 | |
Recruiting |
NCT05604222 -
Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women
|
Phase 4 | |
Recruiting |
NCT05806164 -
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
|
Phase 4 | |
Completed |
NCT01505439 -
A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence
|
Phase 4 | |
Recruiting |
NCT04731961 -
Reduction in Number of Botox Injections for Urgency Urinary Incontinence
|
N/A | |
Recruiting |
NCT04227184 -
Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence
|
Phase 4 | |
Completed |
NCT02833402 -
Sacral Neuromodulation and the Microbiome
|
||
Completed |
NCT03029624 -
eCoin Tibial Nerve Stimulation for OAB
|
N/A |